Gürol Tuncman

Medicine · Health Sciences

15h-index10.1kcitations27works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Adipose Tissue and Metabolism(8), Peroxisome Proliferator-Activated Receptors(7), Adipokines, Inflammation, and Metabolic Diseases(6), Pancreatic function and diabetes(6), Diabetes Treatment and Management(4)

Publications27 total

Review for "CHIP mediates glucagon action on hepatic glucose production via regulating Smad3 ubiquitination"
2025
Review for "CHIP mediates glucagon action on hepatic glucose production via regulating Smad3 ubiquitination"
2025
FABP4 as a therapeutic host target controlling SARS-CoV-2 infection
EMBO Molecular Medicine·2025· 4 citedOpen Access
An adipo-pulmonary axis mediated by FABP4 hormone defines a target against obesity-induced airway disease
2024
An Adipo-Pulmonary Axis Mediated by FABP4 Hormone Defines a Therapeutic Target Against Obesity-Induced Airway Disease
2024Open Access
FABP4 as a Therapeutic Host Target Controlling SARS-CoV2 Infection
2024· 1 citedOpen Access
Review for "Adipose tissue‐derived <scp>FABP4</scp> mediates glucagon‐stimulated hepatic glucose production in gestational diabetes"
2023
Author Correction: A central role for JNK in obesity and insulin resistance
Nature·2023· 7 citedOpen Access
Review for "Adipose tissue‐derived <scp>FABP4</scp> mediates glucagon‐stimulated hepatic glucose production in gestational diabetes"
2023
Intercellular Transmission of Hepatic ER Stress in Obesity Disrupts Systemic Metabolism
Cell Metabolism·2021· 20 citedOpen Access
Intercellular Transmission of Hepatic ER Stress in Obesity Disrupts Systemic Metabolism
Cell Metabolism·2020· 99 citedOpen Access
The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans
Science Translational Medicine·2019· 271 cited
OR01-1 Leveraging Immunometabolic Control to Prevent and Treat Obesity Related Asthma
Journal of the Endocrine Society·2019· 1 citedOpen Access
Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes
Science Translational Medicine·2015· 97 cited
Adipocyte Lipid Chaperone aP2 Is a Secreted Adipokine Regulating Hepatic Glucose Production
Cell Metabolism·2013· 265 citedOpen Access
Double-Stranded RNA-Dependent Protein Kinase Links Pathogen Sensing with Stress and Metabolic Homeostasis
Cell·2010· 498 citedOpen Access
Adipocyte/macrophage fatty acid–binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice
Journal of Clinical Investigation·2008· 327 citedOpen Access
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
Nature·2007· 725 citedOpen Access
Functional <i>in vivo</i> interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance
Proceedings of the National Academy of Sciences·2006· 342 citedOpen Access
A genetic variant at the fatty acid-binding protein <i>aP2</i> locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease
Proceedings of the National Academy of Sciences·2006· 277 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Gökhan S. Hotamışlıgil(19), Cem Z. Görgün(7), M. Furkan Burak(7), Masato Furuhashi(4), Amir Tirosh(4), Ediz S. Calay(4), Karen Inouye(4), Jiro Hirosumi(3), Lufen Chang(3), Michael Karin(3), Haiming Cao(3), M. Rathaus(3), Idit Ron(3), Rinat Livne(3), Işık Bökesoy(3), K. Teoman Uysal(2), Kazuhisa Maeda(2), Eric Vaillancourt(2), Eric B. Rimm(2), Kosei Eguchi(2)